Trial intelligence / Profile preview

NAC for head trauma-induced anosmia

NCT03680911Phase 3Terminated

Sponsor
University of Miami
Start
Oct 2018
Primary completion
Jan 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of acetylcysteine in anosmia, sponsored by University of Miami. Started Oct 2018; status: terminated.

02

Drugs

acetylcysteine
03

Conditions

anosmia

Beyond the preview

Go deeper on NCT03680911.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03680911.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call